Related references
Note: Only part of the references are listed.A Novel Marine Drug, SZ-685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR-200c
C. -H. Chen et al.
CURRENT MEDICINAL CHEMISTRY (2013)
MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer
Hongxia Deng et al.
GENE (2013)
MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro
Giampaolo Trivellin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells
B. Shan et al.
ENDOCRINE-RELATED CANCER (2012)
Altered MicroRNA Expression Profile in Human Pituitary GH Adenomas: Down-Regulation of miRNA Targeting HMGA1, HMGA2, and E2F1
Daniela D'Angelo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
MicroRNAs-based network: A novel therapeutic agent in pituitary adenoma
Xiuhua Shi et al.
MEDICAL HYPOTHESES (2012)
MiR-1 Is a Tumor Suppressor in Thyroid Carcinogenesis Targeting CCND2, CXCR4, and SDF-1α
Vincenza Leone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Co-expression of somatostatin receptor subtypes and estrogen receptor-alpha mRNAs by non-functioning pituitary adenomas in young patients
Hiroshi Nishioka et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells
Lin Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Pituitary tumours: The sst/D2 receptors as molecular targets
Leo J. Hofland et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomas
Xian-Zeng Hou et al.
NEURO-ONCOLOGY (2010)
E2F1 Induces Pituitary Tumor Transforming Gene (PTTG1) Expression in Human Pituitary Tumors
Cuiqi Zhou et al.
MOLECULAR ENDOCRINOLOGY (2009)
Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis
Hexin Chen et al.
CANCER RESEARCH (2008)
miR-206 expression is down-regulated in estrogen receptor α-positive human breast cancer
Naoto Kondo et al.
CANCER RESEARCH (2008)
Expression of MSX1 in human normal pituitaries and pituitary adenomas
Yoshihito Mizokami et al.
ENDOCRINE PATHOLOGY (2008)
Inhibition of NFκB reduces cellular viability in GH3 pituitary adenoma cells
John R. Vender et al.
NEUROSURGERY (2008)
MAZ drives tumor-specific expression of PPAR gamma 1 in breast cancer cells
Xin Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition
Y. Tong et al.
ONCOGENE (2007)
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas
Arianna Bottoni et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Pituitary adenoma predisposition caused by germline mutations in the AIP gene
Outi Vierimaa et al.
SCIENCE (2006)
The Emerging Role of Pituitary Tumor Transforming Gene in Tumorigenesis
Jacob Tfelt-Hansen et al.
CLINICAL MEDICINE & RESEARCH (2006)
Expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in pituitary adenomas
K Kim et al.
ENDOCRINE PATHOLOGY (2005)
Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis
D Phan et al.
CANCER RESEARCH (2004)
Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour
CJ McCabe et al.
CLINICAL ENDOCRINOLOGY (2003)
Expression of cyclin kinase inhibitor p2l/WAF1 protein in pituitary adenomas: Correlations with endocrine activity, but not cell proliferation
H Hiyama et al.
ACTA NEUROCHIRURGICA (2002)